Chase Investment Counsel Corp / VRTX
Chase Investment Counsel Corp’s Vertex Pharmaceuticals Inc Position
Does Chase Investment Counsel Corp own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 6.6K shares worth $3M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q1 2025
Shares
6.6K
% of Portfolio
+1.17%
Quarters Held
15
position exited
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 6.6K | $3M | +1.17% |
| Q4 2024 | 7.0K | $3M | +0.90% |
| Q3 2024 | 7.1K | $3M | +1.09% |
| Q2 2024 | 8.2K | $4M | +1.37% |
| Q1 2024 | 8.1K | $3M | +1.26% |
| Q4 2023 | 6.7K | $3M | +1.21% |
| Q3 2023 | 7.2K | $2M | +1.25% |
| Q2 2023 | 7.1K | $3M | +1.26% |
| Q1 2023 | 7.0K | $2M | +1.22% |
| Q4 2022 | 6.9K | $2M | +1.22% |
| Q3 2022 | 11.4K | $3M | +2.09% |
| Q2 2022 | 8.4K | $2M | +1.28% |
| Q3 2020 | 11.4K | $3M | +1.54% |
| Q2 2020 | 13.3K | $4M | +1.95% |
| Q1 2020 | 16.3K | $4M | +2.61% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Chase Investment Counsel Corp’s full portfolio or all institutional holders of VRTX.